tiprankstipranks
Advertisement
Advertisement

REGN Stock Latest News

Regeneron, Circle, Burlington, Ross, Pembina Trending With Analysts
Weekend UpdatesRegeneron, Circle, Burlington, Ross, Pembina Trending With Analysts
4d ago
PBA
BURL
Regeneron’s ROXI-PALISADE Trial Targets Safer Clot Prevention in Peripheral Artery Disease
PremiumCompany Announcements
Regeneron’s ROXI-PALISADE Trial Targets Safer Clot Prevention in Peripheral Artery Disease
5d ago
REGN
Regeneron says EMA accepted review under AA the MAA for Otarmeni
PremiumThe Fly
Regeneron says EMA accepted review under AA the MAA for Otarmeni
5d ago
REGN
Regeneron’s REGN7544 Trial Reaches Key Milestone in Sepsis-Induced Hypotension
PremiumCompany Announcements
Regeneron’s REGN7544 Trial Reaches Key Milestone in Sepsis-Induced Hypotension
7d ago
REGN
Regeneron price target lowered to $875 from $1,057 at Canaccord
PremiumThe Fly
Regeneron price target lowered to $875 from $1,057 at Canaccord
8d ago
REGN
Regeneron price target lowered to $860 from $900 at Wolfe Research
PremiumThe FlyRegeneron price target lowered to $860 from $900 at Wolfe Research
9d ago
REGN
Midday Fly By: Dominion to combine with NextEra, Publicis to acquire LiveRamp
Premium
The Fly
Midday Fly By: Dominion to combine with NextEra, Publicis to acquire LiveRamp
9d ago
D
F
Regeneron falls -11.1%
Premium
The Fly
Regeneron falls -11.1%
9d ago
REGN
Zscaler upgraded, CoreWeave downgraded: Wall Street’s top analyst calls
PremiumThe Fly
Zscaler upgraded, CoreWeave downgraded: Wall Street’s top analyst calls
9d ago
ZS
ARM
Video: NextEra buying Dominion to form energy giant
PremiumThe Fly
Video: NextEra buying Dominion to form energy giant
9d ago
D
BIO
Morning Movers: LiveRamp jumps following pact to be acquired by Publicis
PremiumThe Fly
Morning Movers: LiveRamp jumps following pact to be acquired by Publicis
9d ago
D
F
Regeneron price target lowered to $825 from $875 at Evercore ISI
PremiumThe Fly
Regeneron price target lowered to $825 from $875 at Evercore ISI
9d ago
REGN
Regeneron price target lowered to $707 from $762 at RBC Capital
PremiumThe FlyRegeneron price target lowered to $707 from $762 at RBC Capital
9d ago
SNY
REGN
Regeneron: Buy Rating and $968 Price Target Reaffirmed Despite Fi Anlimab Setback, Backed by Robust Pipeline and IP Extensions
Premium
Ratings
Regeneron: Buy Rating and $968 Price Target Reaffirmed Despite Fi Anlimab Setback, Backed by Robust Pipeline and IP Extensions
9d ago
REGN
Regeneron price target lowered to $778 from $796 at Truist
Premium
The Fly
Regeneron price target lowered to $778 from $796 at Truist
9d ago
REGN
Regeneron price target lowered to $730 from $900 at BMO Capital
PremiumThe Fly
Regeneron price target lowered to $730 from $900 at BMO Capital
9d ago
REGN
Regeneron enters $125M agreement with Parabilis Medicines
PremiumThe Fly
Regeneron enters $125M agreement with Parabilis Medicines
9d ago
REGN
Regeneron price target lowered to $855 from $875 at Piper Sandler
PremiumThe Fly
Regeneron price target lowered to $855 from $875 at Piper Sandler
9d ago
REGN
Regeneron: Buy Rating Reiterated as Analyst Trims Target to $730 but Sees Long-Term Upside from Core Franchise and Pipeline
PremiumRatings
Regeneron: Buy Rating Reiterated as Analyst Trims Target to $730 but Sees Long-Term Upside from Core Franchise and Pipeline
9d ago
REGN
Regeneron price target lowered to $850 from $950 at JPMorgan
PremiumThe FlyRegeneron price target lowered to $850 from $950 at JPMorgan
9d ago
REGN
Leerink cuts Regeneron to Market Perform on LAG-3 failure, Eylea erosion risk
Premium
The Fly
Leerink cuts Regeneron to Market Perform on LAG-3 failure, Eylea erosion risk
9d ago
REGN
Regeneron downgraded to Market Perform from Outperform at Leerink
Premium
The Fly
Regeneron downgraded to Market Perform from Outperform at Leerink
9d ago
REGN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >